Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Dr. Heiner Dreismann, Former CEO of Roche Molecular Systems and Diagnostics Veteran, Joins Shrink Nanotechnologies Board of Directors

Abstract:
Dr. Dreismann to Also Serve on the Shrink Business Advisory Board; Assist Shrink in Seeking Development Partners for Shrink's Diagnostics Technologies

Dr. Heiner Dreismann, Former CEO of Roche Molecular Systems and Diagnostics Veteran, Joins Shrink Nanotechnologies Board of Directors

Carlsbad, CA | Posted on June 25th, 2009

Shrink Nanotechnologies, Inc. ("Shrink") (OTCBB: INKN), an innovative platform nanotechnology company developing technologies for a number of diverse fields ranging from medical diagnostics to solar cell concentrators, announced that Heiner Dreismann, Ph.D., has joined the company's Board of Directors and will chair Shrink's Business Advisory Board. Dr. Dreismann is the former Chief Executive Officer of Roche Molecular Diagnostics (Roche), a division of F. Hoffmann-La Roche Ltd.

Shrink CEO Mark L. Baum commented, "Dr. Dreismann is one of the top industry experts in the field of molecular and medical diagnostics. He has a proven track-record of leadership in the development, commercialization and adoption of diagnostics, and brings valuable real-world experience as we begin integrating our breakthrough metal-enhanced fluorescence technologies into diagnostics and other life sciences products that can make a difference in people's lives. Dr. Dreismann, throughout his impressive career and consistent successful track record, has developed numerous domestic and international industry contacts which we believe will open doors for our company. We are very pleased to welcome Dr. Dreismann to Shrink and look forward to his active participation and contribution to our success."

Dr. Dreismann added, "After having met with Dr. Khine and the Shrink principals, I am pleased to be part of the team that has developed a very promising platform technology that will bring true innovation to various applications in in-vitro diagnostics, such as heterogeneous immunoassays, point of care products and molecular diagnostics. It is my intent to be an active member of the Board, and intend to bring the wealth of my experience and contacts, which I believe can create real opportunities for our business as we develop products and seek licensing partners for our technologies."

Roche pioneered the clinical implementation of molecular diagnostics. While at Roche, Dr. Dreismann led the introduction in Europe of the company's PCR (polymerase chain reaction) and, now industry-standard, real-time PCR-based tests. PCR is a Nobel-prize winning technology which has been recognized as one of the most important scientific developments of our generation. PCR allows scientists to copy a single segment of DNA billions of times, making it possible to take a specimen, copy its genetic sequence, and, within hours, generate a test sample sufficient to perform a detailed analysis of a specific genetic question.

Under Dr. Dreismann's leadership as Chief Executive Officer, leading a team of more than 1,500 professionals, Roche evolved into one of the world's leading molecular diagnostics companies with annual sales to over US $1.2 billion and the significant expansion of their portfolio of diagnostic tests and hardware. Prior to his appointment as Chief Executive Officer, Dr. Dreismann held other senior positions within Roche in the areas of Global Business Development, Business Unit Manager for PCR and Microbiology, as well as R&D positions in microbiology and infectious diseases and in manufacturing.

Dr. Dreismann holds a Masters Degree in Biology and a Ph.D. in Microbiology/Molecular Biology from Westfaelische Wilhelms University in Muenster, Germany.

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 that involve risks, uncertainties and assumptions, including statements about the markets for and uses of products described in this press release and other technologies which Shrink Nanotechnologies, Inc. seeks to commercialize. Actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of several factors including unanticipated delays in the completion of the commercialization of Shrink Nanotechnologies, Inc.'s products and the market appetite for Shrink's services. Specifically, no assurance can be made that Dr. Dreismann, alone or in conjunction with any relationship he has, will be able to yield any strategic relationship for Shrink. The forward-looking statements made herein speak only as of the date of this press release and the company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

####

About Shrink Nanotechnologies
Shrink brings together leading scientists, business advisors and an executive team that is dedicated to bringing its technology to the commercial marketplace. Shrink solutions, including its substrates, devices and research tools are being designed to not only be mechanically effective in the solar energy, environmental detection, stem cell and biotechnology markets, they are also being made from biodegradable materials, including corn-based plastics. Shrink has created the Shrink Chip Manufacturing Solution™ which utilizes the unique characteristics of Shrink Chips™. Made from a shrinkable thermo-plastic material, Shrink Chips™ enable complex structures to be designed at the macro-scale, while retaining the original designs on a much smaller scale. This flexible and elegant design and fabrication solution reduces costs by eliminating the need for expensive clean room equipment, vastly improving time-to-market for products in Shrink’s focused market segments.

For more information, please click here

Contacts:
Shrink Nanotechnologies, Inc.
Mark L. Baum, Esq., 760-804-8844 x205

Copyright © Business Wire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

UCF Nanotech Spinout Developing Revolutionary Battery Technology: Power the Next Generation of Electronics with Carbon July 23rd, 2014

Deadline Announced for Registration in 7th Int'l Nanotechnology Festival in Iran July 23rd, 2014

A Crystal Wedding in the Nanocosmos July 23rd, 2014

Nano-sized Chip "Sniffs Out" Explosives Far Better than Trained Dogs: TAU researcher's groundbreaking sensor detects miniscule concentrations of hazardous materials in the air July 23rd, 2014

Announcements

UCF Nanotech Spinout Developing Revolutionary Battery Technology: Power the Next Generation of Electronics with Carbon July 23rd, 2014

Deadline Announced for Registration in 7th Int'l Nanotechnology Festival in Iran July 23rd, 2014

A Crystal Wedding in the Nanocosmos July 23rd, 2014

Nano-sized Chip "Sniffs Out" Explosives Far Better than Trained Dogs: TAU researcher's groundbreaking sensor detects miniscule concentrations of hazardous materials in the air July 23rd, 2014

Appointments/Promotions/New hires/Resignations/Deaths

Organometallics welcomes new editor-in-chief: Paul Chirik, Ph.D. July 22nd, 2014

NSS Pays Tribute to Space Pioneer Frederick I. Ordway III July 7th, 2014

Harris & Harris Group Announces Changes to Its Legal Department June 9th, 2014

SEMATECH Appoints Satyavolu Papa Rao to Lead Process Technology May 13th, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE